Quantitative and Temporal Differences in Coagulation, Fibrinolysis and Platelet Activation after On-Pump and Off-Pump Coronary Artery Bypass Surgery

Heart Lung and Circulation

Volumn 18, Issue 2, 2009, Pages 123-130

  Vallely, Michael P ^a,b   Bannon, Paul G ^a,b,c   Bayfield, Matthew S ^a,b   Hughes, Clifford F ^a,b,c   Kritharides, Len ^a,c,d  

^a The Baird Institute Australia   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c University of Sydney   (Australia)

^d Concord Repatriation and General Hospital ^*  (Australia)

Author keywords

Cardiac surgery; Cardiopulmonary bypass; Off pump surgery

Indexed keywords

BLOOD CLOTTING FACTOR 7A; D DIMER; HEPARIN; PADGEM PROTEIN; PLASMINOGEN; PROTAMINE; PROTHROMBIN; THROMBIN; THROMBOPLASTIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; FEMALE; FIBRINOLYSIS; HUMAN; INTERMETHOD COMPARISON; MALE; OFF PUMP CORONARY SURGERY; POSTOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION FACTORS; CORONARY ARTERY BYPASS, OFF-PUMP; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; THROMBOEMBOLISM;

EID: 63249134363     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2008.08.012     Document Type: Article

References (36)

1. Parolari A., Mussoni L., Frigerio M., Naliato M., Alamanni F., Galanti A., Fiore G., Veglia F., Tremoli E., Biglioli P., and Camera M. Increased prothrombotic state lasting as long as one month after on-pump and off-pump coronary surgery. J Thorac Cardiovasc Surg 130 2 (2005) 303-308
2. Casati V., Guerra F., and D'Angelo A. About the activation of the coagulation system during on-pump and off-pump coronary surgery and the use of antifibrinolytic drugs. J Thorac Cardiovasc Surg 132 3 (2006) 733-734 (author reply 734)
3. Biglioli P., Cannata A., Alamanni F., Naliato M., Porqueddu M., Zanobini M., Tremoli E., and Parolari A. Biological effects of off-pump vs. on-pump coronary artery surgery: focus on inflammation, hemostasis and oxidative stress. Eur J Cardiothorac Surg 24 2 (2003) 260-269
4. Wahba A., Rothe G., Lodes H., Barlage S., and Schmitz G. The influence of the duration of cardiopulmonary bypass on coagulation, fibrinolysis and platelet function. Thorac Cardiovasc Surg 49 3 (2001) 153-156
5. Mariani M.A., Gu Y.J., Boonstra P.W., Grandjean J.G., van Oeveren W., and Ebels T. Procoagulant activity after off-pump coronary operation: is the current anticoagulation adequate?. Ann Thorac Surg 67 5 (1999) 1370-1375
6. Casati V., Gerli C., Franco A., Della Valle P., Benussi S., Alfieri O., Torri G., and D'Angelo A. Activation of coagulation and fibrinolysis during coronary surgery: on-pump versus off-pump techniques. Anesthesiology 95 5 (2001) 1103-1109
7. Vallely M.P., Bannon P.G., and Kritharides L. The systemic inflammatory response syndrome and off-pump cardiac surgery. Heart Surg Forum 4 Suppl 1 (2001) S7-S13
8. Cardigan R.A., Hamilton-Davies C., McDonald S., Purdy G., Mackie I.J., Webb A.R., and Machin S.J. Haemostatic changes in the pulmonary blood during cardiopulmonary bypass. Blood Coagul Fibrinol 7 5 (1996) 567-577
9. Chung J.H., Gikakis N., Rao A.K., Drake T.A., Colman R.W., and Edmunds Jr. L.H. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. Circulation 93 11 (1996) 2014-2018
10. Knudsen L., Hasenkam J.M., Kure H.H., Hughes P., Bellaiche L., Ahlburg P., and Djurhuus C. Monitoring thrombin generation with prothrombin fragment 1, 2 assay during cardiopulmonary bypass surgery. Thromb Res 84 1 (1996) 45-54
11. Tsang G.M., Allen S., Pagano D., Wong C., Graham T.R., and Bonser R.S. von Willebrand factor and urinary albumin excretion are possible indicators of endothelial dysfunction in cardiopulmonary bypass. Eur J Cardiothorac Surg 13 4 (1998) 385-391
12. Burman J.F., Chung H.I., Lane D.A., Philippou H., Adami A., and Lincoln J.C. Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypass. Lancet 344 8931 (1994) 1192-1193
13. Boisclair M.D., Lane D.A., Philippou H., Esnouf M.P., Sheikh S., Hunt B., and Smith K.J. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood 82 11 (1993) 3350-3357
14. Koster A., Fischer T., Praus M., Haberzettl H., Kuebler W.M., Hetzer R., and Kuppe H. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management. Anesthesiology 97 4 (2002) 837-841
15. Philippou H., Adami A., Davidson S.J., Pepper J.R., Burman J.F., and Lane D.A. Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass. Thromb Haemost 84 1 (2000) 124-128
16. Ernofsson M., Thelin S., and Siegbahn A. Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study. J Thorac Cardiovasc Surg 113 3 (1997) 576-584
17. Valen G., Blomback M., Sellei P., Lindblom D., and Vaage J. Release of von Willebrand factor by cardiopulmonary bypass, but not by cardioplegia in open heart surgery. Thromb Res 73 1 (1994) 21-29
18. Perrin E.J., Ray M.J., and Hawson G.A. The role of von Willebrand factor in haemostasis and blood loss during and after cardiopulmonary bypass surgery. Blood Coagul Fibrinol 6 7 (1995) 650-658
19. Tabuchi N., de Haan J., Boonstra P.W., and van Oeveren W. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass. J Thorac Cardiovasc Surg 106 5 (1993) 828-833
20. Nguyen N.T., Owings J.T., Gosselin R., Pevec W.C., Lee S.J., Goldman C., and Wolfe B.M. Systemic coagulation and fibrinolysis after laparoscopic and open gastric bypass. Arch Surg 136 8 (2001) 909-916
21. Hunt B.J., Parratt R.N., Segal H.C., Sheikh S., Kallis P., and Yacoub M. Activation of coagulation and fibrinolysis during cardiothoracic operations. Ann Thorac Surg 65 3 (1998) 712-718
22. Rifon J., Paramo J.A., Prosper F., Collados M.T., Sarra J., and Rocha E. Thrombin-antithrombin complexes and prothrombin fragment 1+2 in aorto-coronary bypass surgery: relation to graft occlusion. Hematol Pathol 8 1-2 (1994) 35-42
23. Zajtchuk R., Collins G.J., Holley P.W., Heydron W.H., Schuchmann G.F., and Hamaker W.R. Coagulation factors influencing thrombosis of aorta-coronary bypass grafts. J Thorac Cardiovasc Surg 73 2 (1977) 309-311
24. Woo Y.J., Atluri P., Grand T.J., Hsu V., and Gardner T.J. Should standard on-pump protamine dosing formulas be recalculated for off-pump coronary artery bypass grafting?. Heart Surg Forum 7 1 (2004) 42-44
25. Tanaka K.A., Thourani V.H., Williams W.H., Duke P.G., Levy J.H., Guyton R.A., and Puskas J.D. Heparin anticoagulation in patients undergoing off-pump and on-pump coronary bypass surgery. J Anesth 21 3 (2007) 297-303
26. Hangler H.B., Pfaller K., Ruttmann E., Hoefer D., Schachner T., Laufer G., and Antretter H. Effects of intracoronary shunts on coronary endothelial coating in the human beating heart. Ann Thorac Surg 77 3 (2004) 776-780
27. Rifon J., Paramo J.A., Panizo C., Montes R., and Rocha E. The increase of plasminogen activator inhibitor activity is associated with graft occlusion in patients undergoing aorto-coronary bypass surgery. Br J Haematol 99 2 (1997) 262-267
28. Moor E., Blomback M., Silveira A., Wiman B., Cederlund K., Bergstrand L., Ivert T., Ryden L., and Hamsten A. Haemostatic function in patients undergoing coronary artery bypass grafting: peroperative perturbations and relations to saphenous vein graft closure. Thromb Res 98 1 (2000) 39-49
29. Ray M.J., Marsh N.A., and Hawson G.A. Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass. Blood Coagul Fibrinol 5 5 (1994) 679-685
30. Komai H., and Haworth S.G. Effect of cardiopulmonary bypass on the circulating level of soluble GMP-140. Ann Thorac Surg 58 2 (1994) 478-482
31. Wei M., Kuukasjarvi P., Laurikka J., Kaukinen S., Iisalo P., Laine S., and Tarkka M. Soluble adhesion molecules and myocardial injury during coronary artery bypass grafting. World J Surg 27 2 (2003) 140-144
32. Parolari A., Mussoni L., Frigerio M., Naliato M., Alamanni F., Polvani G.L., Agrifoglio M., Veglia F., Tremoli E., Biglioli P., and Camera M. The role of tissue factor and P-selectin in the procoagulant response that occurs in the first month after on-pump and off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg 130 6 (2005) 1561-1566
33. Ballotta A., Saleh H.Z., El Baghdady H.W., Gomaa M., Belloli F., Kandil H., Balbaa Y., Bettini F., Bossone E., Menicanti L., Frigiola A., Bellucci C., and Mehta R.H. Comparison of early platelet activation in patients undergoing on-pump versus off-pump coronary artery bypass surgery. J Thorac Cardiovasc Surg 134 1 (2007) 132-138
34. Ley K. Molecular mechanisms of leukocyte recruitment in the inflammatory process. Cardiovasc Res 32 4 (1996) 733-742
35. Lotan D., Prince T., Dagan O., Keller N., Ben-Abraham R., Weinbroum A., Gaby A., Augarten A., Smolinski A., Barzilay Z., and Paret G. Soluble P-selectin and the postoperative course following cardiopulmonary bypass in children. Paediatr Anaesth 11 3 (2001) 303-308
36. Hayashi Y., Sawa Y., Nishimura M., Tojo S.J., Ichikawa H., Satoh H., Yamaguchi T., Suhara H., Ohtake S., and Matsuda H. P-selectin monoclonal antibody may attenuate the whole body inflammatory response induced by cardiopulmonary bypass. Asaio J 46 3 (2000) 334-337